NarinApisarnthanaraxMD

PubMed

• 16 citations
  Phase I Clinical Trial of O6-Benzylguanine and Topical Carmustine in the Treatment of Cutaneous T-Cell Lymphoma, Mycosis Fungoides Type
  Narin Apisarnthanarax, Gary S. Wood, Seth R. Stevens, Sean Carlson, Derek V. Chan, Lili Liu, Sarolta K. Szabo, Pingfu Fu, Anita C. Gilliam, Stanton L. Gerson, Scot C. ...> ;Archives of Dermatology. 2012 May 1
• 19 citations
  Usefulness of flow cytometry in the diagnosis of mycosis fungoides.
  Shaheen Oshtory, Narin Apisarnthanarax, Anita C. Gilliam, Kevin D. Cooper, Howard J. Meyerson> ;Journal of the American Academy of Dermatology. 2007 Sep 1
• 104 citations
  Phase II evaluation of gemcitabine monotherapy for cutaneous T-cell lymphoma.
  Madeleine Duvic, Rakhshandra Talpur, Sijin Wen, Razelle Kurzrock, Cynthia L. David, Narin Apisarnthanarax> ;Clinical Lymphoma & Myeloma. 2006 Jul 1
• 76 citations
  CD25 Expression Is Correlated with Histological Grade and Response to Denileukin Diftitox in Cutaneous T-Cell Lymphoma
  Rakhshandra Talpur, Dan Jones, Alvaro J. Alencar, Narin Apisarnthanarax, Kelly L. Herne, Ying Yang, Madeleine Duvic> ;The Journal of Investigative Dermatology. 2006 Mar 1
• 37 citations
  Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study
  Narin Apisarnthanarax, Rakhshandra Talpur, Staci Ward, Xiao Ni, Hyung Woo Kim, Madeleine Duvic> ;Journal of the American Academy of Dermatology. 2004 Apr 1
• 48 citations
  Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma
  Madeleine Duvic, Narin Apisarnthanarax, Deborah S. Cohen, Terry L. Smith, Chul S. Ha, Razelle Kurzrock> ;Journal of the American Academy of Dermatology. 2003 Jul 1
• 10 citations
  Mycosis fungoides with follicular mucinosis displaying aggressive tumor-stage transformation : successful treatment using radiation therapy plus oral bexarotene combin...
  Narin Apisarnthanarax, Chul S. Ha, Madeleine Duvic> ;American Journal of Clinical Dermatology. 2003 Jun 27
• 10 citations
  Optimizing bexarotene therapy for cutaneous T-cell lymphoma.
  Rakhshandra Talpur, Staci Ward, Narin Apisarnthanarax, Joan Breuer-Mcham, Madeleine Duvic> ;Journal of the American Academy of Dermatology. 2002 Nov 1
• 12 citations
  Therapy options in cutaneous T-cell lymphoma
  Narin Apisarnthanarax, Madeleine Duvic> ;Expert Review of Anticancer Therapy. 2001 Oct 1
• 60 citations
  Treatment of cutaneous T cell lymphoma: current status and future directions.
  Narin Apisarnthanarax, Rakhshandra Talpur, Madeleine Duvic> ;American Journal of Clinical Dermatology. 2002 Jan 1
• 48 citations
  Treatment of refractory peripheral T-cell lymphoma with denileukin diftitox (ONTAK).
  Rakhshandra Talpur, Narin Apisarnthanarax, Staci Ward, Madeleine Duvic> ;Leukemia & Lymphoma. 2002 Jan 1
• 2 citations
  Cryofibrinogenemia in a patient with B-cell lymphoma.
  Jo Ann Lee, Narin Apisarnthanarax, Robert E. Jordon, Madeleine Duvic> ;Clinical Lymphoma. 2000 Dec 1
• 8 citations
  CUTANEOUS T-CELL LYMPHOMA: New Immunomodulators
  Narin Apisarnthanarax, Madeleine Duvic> ;Dermatologic Clinics. 2001 Oct 1
• 50 citations
  Response of keratinocytes from normal and psoriatic epidermis to interferon-gamma differs in the expression of zinc-alpha(2)-glycoprotein and cathepsin D.
  San-Hwan Chen, Istvan Arany, Narin Apisarnthanarax, Srinivasan Rajaraman, Stephen K. Tyring, T. Horikoshi, Henry Brysk, Miriam M. Brysk> ;FASEB Journal. 2000 Mar 1
• Failure to detect human papilloma virus in cutaneous molluscum contagiosum lesions.
  Apisarnthanarax, N., Payne, D., Yen, A., Tyring, S.> ;Anticancer Res. 1998 Mar 12
• Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cel...
  Apisarnthanarax, N., Donato, M., Körbling, M., Couriel, D., Gajewski, J., Giralt, S., Khouri, I., Hosing, C., Champlin, R., Duvic, M., Anderlini, P.> ;Bone Marrow Transplant. 2003 Mar
• Join now to see all